Liver biopsy 2005: when and how?

Cleve Clin J Med

Section of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center/Dartmouth Medical School, Lebanon, NH 03756, USA.

Published: March 2005

AI Article Synopsis

  • Advances in clinical imaging and serologic testing are reducing the need for biopsies in diagnosing hepatic diseases.
  • Biopsies are still essential for staging hepatitis C, diagnosing fatty liver disease, identifying tumors, and monitoring treatment effectiveness.
  • Before performing a biopsy, it's crucial to assess the reasons for the procedure, its risks, and clarify the responsibilities among involved healthcare providers.

Article Abstract

Clinical imaging and serologic testing are increasingly replacing biopsy for diagnosing hepatic diseases. However, more biopsies are being done to stage and grade hepatitis C and fatty liver disease, to diagnose space-occupying lesions (typically with fine-needle aspiration biopsy), and to assess response to therapy. If biopsy is planned, it is important to evaluate its indications and risks and, if other physicians are involved, who is responsible for what.

Download full-text PDF

Source
http://dx.doi.org/10.3949/ccjm.72.3.199DOI Listing

Publication Analysis

Top Keywords

liver biopsy
4
biopsy 2005
4
2005 how?
4
how? clinical
4
clinical imaging
4
imaging serologic
4
serologic testing
4
testing increasingly
4
increasingly replacing
4
replacing biopsy
4

Similar Publications

Background And Aims: Alcohol-related liver disease (ALD) is one of the leading causes of severe liver disease with limited pharmacological treatments for alcohol-related steatohepatitis (ASH). CD44, a glycoprotein mainly expressed in immune cells, has been implicated in multiple inflammatory diseases but has never been studied in the ALD context. We therefore studied its contribution to ASH development in mice and its expression in ALD patients.

View Article and Find Full Text PDF

ADAR is highly expressed and correlated with poor prognosis in hepatocellular carcinoma (HCC), yet the role of its constitutive isoform ADARp110 in tumorigenesis remains elusive. We investigated the role of ADARp110 in HCC and underlying mechanisms using clinical samples, a hepatocyte-specific knock-in mouse model, and engineered cell lines. ADARp110 is overexpressed and associated with poor survival in both human and mouse HCC.

View Article and Find Full Text PDF

[Infrequent association of OEIS complex with a diaphragmatic defect].

Andes Pediatr

August 2023

Programa Madre Canguro /Alto riesgo neonatal Subred Sur-UMHES-MEISSEN, Bogotá, Colombia.

Unlabelled: Omphalocele-exstrophy-imperforate anus-spinal defects (OEIS) complex is a rare entity that presents abdominal wall defects, entails high morbidity and mortality, and requires multidisciplinary management.

Objective: To describe a case with an unusual association between OEIS complex and diaphragmatic hernia and to discuss its pathogenesis and possible association with other midline malformations.

Clinical Case: A preterm female newborn of 33 weeks of gestational age, with prenatal diagnosis of giant omphalocele that, at birth, presented intact amnion coverture containing the entire liver and some bowel loops, open bladder exstrophy and exposed urethral orifices; uterus didelphys, no palpable gonads, and concurrent imaging findings of pelvic soft tissue extrusion, left diaphragmatic hernia (Bochdalek), multiple bone defects, myelomeningocele, and myelocystocele.

View Article and Find Full Text PDF

The multifaceted roles of aldolase A in cancer: glycolysis, cytoskeleton, translation and beyond.

Hum Cell

January 2025

Institute of Translational Medicine, Medical College, Yangzhou University, No. 136 Jiangyangzhonglu, Yangzhou, 225009, Jiangsu, China.

Cancer, a complicated disease characterized by aberrant cellular metabolism, has emerged as a formidable global health challenge. Since the discovery of abnormal aldolase A (ALDOA) expression in liver cancer for the first time, its overexpression has been identified in numerous cancers, including colorectal cancer (CRC), breast cancer (BC), cervical adenocarcinoma (CAC), non-small cell lung cancer (NSCLC), gastric cancer (GC), hepatocellular carcinoma (HCC), pancreatic cancer adenocarcinoma (PDAC), and clear cell renal cell carcinoma (ccRCC). Moreover, ALDOA overexpression promotes cancer cell proliferation, invasion, migration, and drug resistance, and is closely related to poor prognosis of patients with cancer.

View Article and Find Full Text PDF

Background: Pediatric ultrasound (US)-guided percutaneous liver biopsy is a commonly performed procedure in children, and may be performed in a variety of clinical settings. However, there is little research on the relative costs associated with different sedation methods and locations.

Objective: This study uses time-driven activity-based costing (TDABC) to identify relevant costs associated with different biopsy sedation techniques and locations to help inform providers and patients as well as guide value-conscious care.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!